Application of CRISPR/Cas9 Genome Editing to Improve Recombinant Protein Production in CHO Cells

Lise Marie Grav,Johan Blatt Rojek,Karen Julie la Cour Karottki,Jae Seong Lee,Helene Faustrup Kildegaard

DOI: https://doi.org/10.1007/978-1-0716-4104-0_5

Abstract:Genome editing has become an important aspect of Chinese hamster ovary (CHO) cell line engineering for improving the production of recombinant protein therapeutics. Currently, the engineering focus is directed toward expanding product diversity while controlling and improving product quality and yields. In this chapter, we present our protocol for using the genome editing tool Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)/CRISPR-associated protein 9 (Cas9) to knock out engineering target genes in CHO cells. As an example, we describe how to knock out the glutamine synthetase (GS) gene, which increases the selection efficiency of the GS-mediated gene amplification system.